Essayer OR - Gratuit

MoA reports 95% fund utilisation by research councils in last 5-year

Chronicle Pharmabiz

|

August 21, 2025

THE three autonomous bodies conducting R&D activities under the Union Ministry of Ayush (MoA) have utilised more than 97% of the budget released during the last five years, while another one has utilised over 95% of the allocated fund during the period, according to the Ministry.

- Gireesh Babu

The research councils Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council of Research in Homoeopathy (CCRH), and Central Council of Research in Siddha (CCRS) has been actively contributing to the integration of Ayush systems with the modern system of medicine through a range of research initiatives.

According to data from the Ministry, CCRAS has utilised 97.4% of the allocated Rs. 1,814.71 crore, at Rs. 1,767.35 crore, while CCRUM has utilised 97.1% of the allocated Rs. 901.94 crore at Rs. 875.61 crore, and CCRH utilised 98.75% of Rs. 720.78 crore allocated, at Rs. 711.8 crore during the last five years.

CCRS has utilised 95.3% of the allocated Rs. 228.09 crore, at Rs 217.37 crore during the period.

As part of initiatives to strengthen its research activities, the CCRAS has initiated the process of obtaining NABH, NABL, and BIS certifications for its research institutes, in order to enhance institutional quality and credibility.

These accreditations aim to align the institutes with nationally accepted standards in healthcare services, laboratory practices, and operational protocols. Simultaneously, CCRAS is implementing focused capacity-building initiatives to strengthen the skills and competencies of its scientific and administrative staff.

Chronicle Pharmabiz

Cette histoire est tirée de l'édition August 21, 2025 de Chronicle Pharmabiz.

Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.

Déjà abonné ?

PLUS D'HISTOIRES DE Chronicle Pharmabiz

Chronicle Pharmabiz

Miltenyi Biotec, THSTI to set up cell mfg programme

IN a milestone step toward strengthening India's cell and gene therapy (CGT) ecosystem, Miltenyi Biotec, a global leader in CGT technologies, has signed a Letter of Intent (LOI) with the Translational Health Science and Technology Institute (THSTI) to establish India's first hands-on training programmes in clinical cell manufacturing.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

MDC asks Abbott Healthcare to avoid negligence while filing price details

THE Multi Disciplinary Committee (MDC) of Experts, which advises the National Pharmaceutical Pricing Authority (NPPA) on pricing matters, has directed Abbott Healthcare to avoid negligence in filing proper details while submitting the price related details in the Integrated Pharmaceutical Database Management System (IPDMS).

time to read

1 mins

August 21, 2025

Chronicle Pharmabiz

Greenspace Herbs unveils 'Quantum Ayurveda'

GREENSPACE Herbs, a leading botanical ingredients company, announced the commercial launch of Quantum Ayurveda, an advanced technology platform that enhances traditional herbal ingredients using quantum resonance principles.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

Gandhi Automations ensuring clean room integrity with high-speed doors

GANDHI Automations Pvt Ltd offers prime clean reset high-speed doors to ensure clean room integrity, minimize air permeability and leakages.

time to read

3 mins

August 21, 2025

Chronicle Pharmabiz

Haryana DC officials raid unregistered clinic in Karnal

In a swift response to a complaint regarding illegal medical practice, a team of health and drug control officials raided an unregistered clinic in Karnal in Haryana, leading to the arrest of an individual found to be practicing medicine without proper medical qualification.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

Guj attracts investments from 100 cr to 5,000 cr

GUJARAT has attracted big ticket investments from MNCs and Indian companies as part of 376 Memorandum of Understandings (MoUs) ranging from Rs. 100 crore to Rs. 5,000 crore, informed Dr H G Koshia, Commissioner of the Gujarat Food & Drug Control Administration (FDCA).

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

'Industry's diversification to EU markets is acting as a buffer against US trade shocks'

INDIAN Pharma industry's diversification into European markets is acting as a buffer against US trade shocks, says Parag Bhatia, director, Laborate Pharmaceuticals.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

Pharma, CROs turn to hybrid cloud infra to safeguard patient information

PHARMA companies and clinical research organizations (CROs) are increasingly adopting hybrid cloud infrastructure to safeguard sensitive patient information.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

'India's PLI scheme transforms pharma industry from policy to practice'

INDIA'S production linked incentive (PLI) scheme has emerged as a transformative policy aimed at revitalizing the pharmaceutical sector and its global competitiveness.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

CDSCO cancels Proteos' Indian agent's import regn

THE Cosmetics Division of the Central Drugs Standard Control Organisation (CDSCO) has cancelled the registration certificate of NKG Advisory Business and Consulting Services to sell the cosmetic products of Spanish cosmetics maker Proteos Biotech, based on the former's request.

time to read

1 min

August 21, 2025

Listen

Translate

Share

-
+

Change font size